PAVMED INC (PAVM)

US70387R4039 - Common Stock

2.25  +0.06 (+2.74%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
500K380K
-24.00%		2.452M
545.26%		6.04M
146.33%
EBITDA
YoY % growth
-54.16M
-132.15%		-88.47M
-63.35%		-65.863M
25.55%		-53.856M
18.23%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
-54.39M
-132.93%		-90.93M
-67.18%		-68.795M
24.34%		-62.749M
8.79%
Operating Margin
-10,878.00%-23,928.95%-2,805.67%-1,038.88%
EPS
YoY % growth
-0.62
-6.90%		-4.23
-582.26%		-9.16
-116.55%		-5.96
34.90%		N/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-1.71
40.11%
Revenue
Q2Q % growth		1.074M
138.67%
EBITDA
Q2Q % growth		-13.413M
EBIT
Q2Q % growth		-15.448M
24.27%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -1.81
47.54%		-1.930.126.11%
Q3 2023
Q2Q % growth		 -2.40
-727.59%		-2.09-0.31-14.77%
Q2 2023
Q2Q % growth		 -2.10
-624.14%		-2.910.8127.76%
Q1 2023
Q2Q % growth		 -2.85
-1,325.00%		-3.160.319.87%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 1.049M
853.64%		1.069M-20K-1.87%
Q3 2023
Q2Q % growth		 790K
887.50%		671.16K118.84K17.71%
Q2 2023
Q2Q % growth		 170K
∞%		535.5K-365.5K-68.25%
Q1 2023
Q2Q % growth		 450K
136.84%		408K42K10.29%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 6.52% 14.06% 14.06%
Revenue-2.27% 2.68% -26.28% -26.28%